Abstract:Background Candida species are commonly detected as colonizers of the oral cavity; candidiasis or candidemia can develop in patients who are immunocompromised. Use of topical or inhaled glucocorticoids can alter the spectrum of Candida species and can promote oral candidiasis. The present study aims to evaluate the diversity of Candida species in the oral cavity and their susceptibility to antifungal agents in patients undergoing treatment with systemic glucocorticoids (SGCs) compared with non-users. Methods We conducted a descriptive, analytical, cross-sectional study that enrolled 120 patients with oral problems who were undergoing treatment with SGCs and who were admitted to the hospital of the First Affiliated Hospital, College of Medicine, Zhejiang University and Zhejiang Hospital, Hangzhou, China, between February 2019 and September 2019. One hundred and twenty age-and sex-matched patients were recruited as the SGC non-user control group. Demographic data included oral complaints and underlying diseases; symptoms of oral candidiasis were identified on physical examination. Candida species were collected using a concentrated oral rinse. Identification of fungal isolates was based on conventional phenotypic methods assisted by DNA sequence analysis of the internal transcribed spacer (ITS) rDNA gene region. Antifungal activities of anidulafungin, amphotericin B, micafungin, caspofungin, 5-flucytosine, posaconazole, voriconazole, itraconazole, and fluconazole were evaluated using the Sensititre YeastOneTM YO10 panel supplemented by the CLSI-M27-A3 protocol. Results Fifty-two (43.33%) out of the 120 patients undergoing with SGCs were diagnosed with oral candidiasis, compared with 14 (11.67%) of the non-users (P < 0.05). Likewise, we collected 88 strains from 73.33% of the SGC users compared with only 48 (40%) from non-users (P < 0.05). Candida albicans was detected most frequently in both groups (45.45% vs 66.67%, respectively; P = 0.033); the overall frequency of non-Candida albicans (NCA) strains isolated from patients treated with SGCs were significantly higher than that identified among non-users (51.14% vs 33.33%, respectively; P = 0.046), although there were no significant differences concerning any single species of NCA. Resistance of C. albicans to itraconazole (P = 0.004) and fluconazole (P = 0.001) was significantly higher in patients treated with SGCs than in non-users; however, echinocandins, amphotericin B, voriconazole, and posaconazole were all active against strains from both participant groups with no significant differences detected. Conclusion Taken together, our findings indicate that SGC therapy may result in an increased prevalence of oral candidiasis as reflected by the clinical presentations and strains isolated; these findings were also associated with an increased frequency of NCA strains. SGC therapy was also associated with an increased frequency of C. albicans strains that were resistant to both itraconazole and fluconazole. The impact of SGC therapy on Candida species in the oral cavity requires further study.

Investigation on the Virulence of Candida Albicans Isolated from Throat in Patients with CTDs

Oral Prevalence of Candida Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates

[In Vitro Study of Oral Candida Albicans in Virulence from HIV-positive Individuals].

Particular Candida Albicans Strains in the Digestive Tract of Dyspeptic Patients, Identified by Multilocus Sequence Typing

Difference between enzymic activity and virulence of dimorphism in candida albicans

Detection of some virulence factors among Candida albicans isolated from patients and prevalence of candidalysin gene CEEc1

Effects of Candida Albicans Infection on Defense Effector Secretion by Human Oral Mucosal Epithelial Cells.

Comparison of biological characteristics and cytopathogenicities between T3SS1 and T3SS2 in Vibrio parahaemolyticus

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

Comparative Analysis of Epidemiological and Clinical Characteristics Between Invasive Candida Infection Versus Colonization in Critically Ill Patients in a Tertiary Hospital in Anhui, China

Stimulation the expression of Toll-like receptor 2 mRNA by Candida albicans at cultured human vaginal epithelial cells in vitro

Correlation Between Seventy-Three Patients with Crohn's Disease and Mycobacterium Avium Subspecies Paratuberculosis Infection

Detection of Virulence Factors from Candida spp. Isolated from Oral and Vaginal Candidiasis in Iraqi Patients

Research Advance on Candida Albicans Hyphal Wall Protein 1

Etiology and risk factors analysis of oral candidiasis in patients with chronic obstructive pulmonary disease

The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.

Variations in candidalysin amino acid sequence influence toxicity and host responses

Molecular Genotyping of Candidaalbicans Isolated from Different Sites May Trace the Etiological Infection Routes: Observation in China

In vitro adherence activity of different genotypes of Candida albicans from patients with vulvovaginal candidiasis

Effects of Candida Albicans on the Expression of Toll-like Receptor 4 Mrna in Cultured Human Vaginal Epithelial Cells

Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis